- Home
- Family Medicine
- Remibrutinib Demonstrates Sustained Efficacy in CSU

2w3 min read
Medical Article
Chronic spontaneous urticaria (CSU) is marked by recurrent hives or angioedema for more than six weeks without clear triggers (1). It significantly disrupts sleep, work, and quality of life (1). Many patients remain uncontrolled on antihistamines, and alternatives are needed (1). Remibrutinib, an oral Bruton’s tyrosine kinase (BTK) inhibitor, offer

Remibrutinib Demonstrates Sustained Efficacy in CSU
1236 Reached1 Comments
Similar Content

Woman presented with Fever of Unknown Origin
7725 Reached93 Comments19 Likes

Rubella Syndrome in Neonate
1400 Reached12 Comments9 Likes

Black Lesion in Old Female
1972 Reached5 Comments11 Likes

Chronic Hyperplastic Candidiasis Of The Oral Mucosa
857 Reached9 Comments11 Likes

Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes